Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
IMP3 encodes the human homolog of the yeast Imp3 protein. De plus, nous expédions IMP3 Protéines (8) et IMP3 Kits (1) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 69 products:
Human Polyclonal IMP3 Primary Antibody pour FACS, IHC (p) - ABIN653856
Li, Yan, Tang, Zhou, Fan, Li, Wang, Xia, Huang, Qiu, Peng: IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. dans Annals of surgical oncology 2010
Show all 4 references for ABIN653856
Human Polyclonal IMP3 Primary Antibody pour EIA, FACS - ABIN952891
Riener, Fritzsche, Clavien, Pestalozzi, Probst-Hensch, Jochum, Kristiansen: IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas. dans Human pathology 2009
Show all 4 references for ABIN952891
Human Polyclonal IMP3 Primary Antibody pour WB - ABIN2779134
Ma, Jin, Liu, Yang, Zheng, Zhang, Miao, Chen: [Comparison of 3 hand-carried ultrasound devices with comprehensive echocardiographic devices in elderly cardiac inpatient examinations]. dans Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation 2008
Show all 2 references for ABIN2779134
Human Polyclonal IMP3 Primary Antibody pour ELISA, WB - ABIN4325734
Walter, Prasad, Lu, Quinlan, Edmiston, Khan: IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype. dans Human pathology 2009
S100P (Montrer S100P Anticorps) achieved 96.4% sensitivity, 93.3% specificity, 98.2% PPV (Montrer PPP6C Anticorps), 87.5% NPV and 95.8% total accuracy, while IMP3 (Montrer IGF2BP3 Anticorps) achieved 91.2% sensitivity, 86.7% specificity, 96.2% PPV (Montrer PPP6C Anticorps), 72.2% NPV and 90.3% total accuracy for pancreatic ductal adenocarcinoma (PDA).Both markers were sensitive and specific for diagnosis of PDA.
This study aimed to demonstrate the usefulness of mRNA expression levels of IMP3 (Montrer IGF2BP3 Anticorps) in brush cytology specimens combined with cytology for the diagnosis of malignant biliary stricture
Tissue overexpression of IMP3 (Montrer IGF2BP3 Anticorps) might be used as a predictor of advanced disease or lymph node metastasis, and is associated with poorer prognosis in gastric cancers.
EGF (Montrer EGF Anticorps) stimulates IMP-3 (Montrer IGF2BP3 Anticorps) expression.
IMP3 (Montrer IGF2BP3 Anticorps) may play a certain role in hydatidiform moles progression, and it may serve as a prognostic biomarker for this disease.
Our results showed that IMP3 (Montrer IGF2BP3 Anticorps) immunostaining has a higher sensitivity and specificity than mesothelin (Montrer MSLN Anticorps) for the diagnosis of pancreatic ductal adenocarcinoma. IMP3 (Montrer IGF2BP3 Anticorps) and mesothelin (Montrer MSLN Anticorps) may be useful markers in distinguishing neoplastic from reactive lesions of the pancreas in instances where this is impossible by morphology alone in surgical pathology practice.
Our study clearly demonstrated differentiation-dependent expression of IMP3 (Montrer IGF2BP3 Anticorps) in chondrosarcoma, and suggests IMP3 (Montrer IGF2BP3 Anticorps) as a novel marker for differentiating problematic cases of enchondroma from well-differentiated chondrosarcomas
IMP3 (Montrer IGF2BP3 Anticorps) directly interacts with ULBP2 (Montrer ULBP2 Anticorps) mRNA, leading to ULBP2 (Montrer ULBP2 Anticorps) transcript destabilization and reduced ULBP2 (Montrer ULBP2 Anticorps) surface expression and indirectly downregulates MICB (Montrer MICB Anticorps) with a mechanism functionally distinct from that of ULBP2 (Montrer ULBP2 Anticorps).
IMP3 (Montrer IGF2BP3 Anticorps) appears to play an important role in tumor invasion in patients with lung adenocarcinoma and may serve as a useful prognostic biomarker in these patients.
IMP3 (Montrer IGF2BP3 Anticorps) represents a biomarker of unfavorable prognosis for clear cell carcinomas of the ovary, even in stage I patients.
IGF2BP3 (Montrer IGF2BP3 Anticorps) regulated transcripts via targeting elements within 3' untranslated regions (3'UTR (Montrer UTS2R Anticorps))
Imp3 (Montrer SPPL2A Anticorps) as a key regulator of stem-like tumorigenic characteristics in osteosarcoma cells
This gene encodes the human homolog of the yeast Imp3 protein. The protein localizes to the nucleoli and interacts with the U3 snoRNP complex. The protein contains an S4 domain.
U3 small nucleolar ribonucleoprotein protein IMP3
, IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast)
, U3 snoRNP protein 3 homolog
, U3 snoRNP protein IMP3
, IGF-II mRNA-binding protein 3
, IGF2 mRNA-binding protein 3
, VICKZ family member 3
, insulin-like growth factor 2 mRNA-binding protein 3
, insulin-like growth factor 2, binding protein 3